Halozyme Therapeutics shares owned by Kennedy Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Kennedy Capital Management
from 13F filings
Historical chart of Kennedy Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Kennedy Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $25M | 663k | 36.96 |
2023-09-30 | $25M | 647k | 38.20 |
2023-06-30 | $22M | 618k | 36.07 |
2023-03-31 | $19M | 504k | 38.19 |
2022-12-31 | $33M | 574k | 56.90 |
2022-09-30 | $26M | 646k | 39.54 |
2022-06-30 | $27M | 602k | 44.00 |
2022-03-31 | $22M | 562k | 39.88 |
2021-12-31 | $22M | 540k | 40.21 |
2021-09-30 | $22M | 549k | 40.68 |
2021-06-30 | $16M | 353k | 45.41 |
2021-03-31 | $15M | 356k | 41.69 |
2020-12-31 | $14M | 333k | 42.71 |
2020-09-30 | $8.8M | 334k | 26.28 |
2020-06-30 | $9.0M | 337k | 26.81 |
2020-03-31 | $6.2M | 344k | 17.99 |
2019-12-31 | $4.1M | 128k | 31.94 |
2019-09-30 | $2.6M | 167k | 15.51 |
2019-06-30 | $3.1M | 178k | 17.18 |
2019-03-31 | $2.9M | 178k | 16.10 |
2018-12-31 | $3.5M | 236k | 14.63 |
2018-09-30 | $11M | 595k | 18.17 |
2018-06-30 | $10M | 608k | 16.87 |
2018-03-31 | $10M | 515k | 19.59 |
2017-12-31 | $10M | 508k | 20.26 |
2017-09-30 | $9.8M | 566k | 17.37 |
2017-06-30 | $7.0M | 546k | 12.82 |
2017-03-31 | $9.0M | 696k | 12.96 |
2016-12-31 | $6.9M | 700k | 9.88 |
2016-09-30 | $6.5M | 539k | 12.08 |
2016-06-30 | $1.0M | 121k | 8.63 |
2016-03-31 | $698k | 74k | 9.47 |
2015-12-31 | $1.2M | 71k | 17.33 |
2015-09-30 | $649k | 48k | 13.43 |
2015-06-30 | $1.1M | 47k | 22.58 |
More positions owned by Kennedy Capital Management
View all positions for Kennedy Capital Management